Kalyan Roy: Swirling as a Simple Indicator of Platelet Quality
Kalyan Roy, Transfusion Medicine Specialist at Square Hospitals LTD, shared a post on LinkedIn:
”What if a simple visual check could reliably indicate platelet quality – without complex testing?
Ensuring the quality and viability of platelet concentrates (PCs) remains a fundamental pillar of modern transfusion medicine, directly influencing patient safety and clinical outcomes.
A large multicenter study across 13 centers, evaluating over 5,000 platelet units, highlights a valuable and practical insight: the visual assessment of ‘swirling’ can serve as a reliable, real-time indicator of platelet quality.
Key Observations from the Study
- Strong correlation with optimal pH
Swirling was consistently associated with pH levels between 6.7–7.5, a range linked to effective in vivo platelet survival. - Indicator of compromised platelet integrity
Approximately 69% of units lacking swirling showed pH values outside the acceptable physiological range (<6.4 or >7.6), suggesting reduced viability. - Unexplained subset requiring further research
Nearly 20% of non-swirling units had normal pH values, indicating additional underlying factors influencing platelet quality.
Why This Matters
Swirling reflects the preservation of the platelet’s discoid morphology, essential for optimal hemostatic function.
Its absence often signals transformation into a spherical form-historically associated with diminished viability and clinical performance.
Implications for Clinical Practice
- Enables rapid, bedside-compatible evaluation
- Offers a non-invasive and cost-effective alternative to complex laboratory assays
- Improves operational efficiency in transfusion services
- Maintains high standards of patient safety with minimal resource burden
In an era where healthcare systems must balance efficiency with excellence, adopting validated, low-cost tools like swirling assessment can significantly enhance routine platelet quality monitoring.”

Other posts featuring Kalyan Roy on Hemostasis Today.
-
Sep 5, 2026, 16:28Jon Douglas: Imperial College London Review Maps Key Pathways in Autoimmune Thrombosis
-
Sep 5, 2026, 16:21Kelly Anderson: Bilateral Foot Pain and Purple Toes – Spotting Vascular Complications in Polycythemia Vera
-
Sep 5, 2026, 16:16Hazem Abosheaishaa: Beta-Blocker Selection Matters – Multi-Institutional Cohort Insights on PVT and Survival in Cirrhosis
-
Sep 5, 2026, 16:08Indre Ceponiene: Major Gaps in Secondary Cardiovascular Prevention Across Europe
-
Sep 5, 2026, 16:03W. Alberto Sifuentes Giraldo: Why Obstetric Cases Are Missed Under 2023 ACR/EULAR APS Criteria
-
Sep 5, 2026, 15:58Srikanth Nalla: A Case of Saddle Pulmonary Embolism
-
Sep 5, 2026, 15:55COPD-specific Pulmonary Embolism Diagnostic Strategy – Thrombosis and Haemostasis
-
Sep 5, 2026, 15:41Sam Tsimikas on Lp(a) HORIZON Topline Results – What Missed Endpoints Mean for Cardiovascular Risk
-
Sep 5, 2026, 15:32Stefano Garzon: SELUTION DeNovo HBR – Weren’t HBR Patients Supposed to Bleed More with DES?